Press Releases

Biodex is often cited in news articles discussing industry trends, new technology and advancements.  There are also times when we find interesting news articles that we like to share with our customers. Outlined below are periodicals where Biodex has been mentioned, corporate press releases, and other relevant industry news. 

Biodex Medical Systems, Inc. and SWE today announced a strategic partnership expanding the global theranostics and nuclear medicine offering in terms of availability and latest market innovation. A natural synergy combines SWE’s new, highly efficient product design with the expansive network of global distributors and expertise of Biodex.

October 12, 2019 – The  absolute revolution of  nuclear medicine with the emergence of theranostics is forcing all stakeholders involved in the process to come up with new, outside-the-box thinking. Reducing exposure, ensuring safe manipulations, reducing weight, size and footprint for transportation while remaining efficient and ergonomically on point is no easy concept. SWE and Biodex joining forces provides innovative solutions that will address these paradigms increasing throughput, saving cost and comply with strict regulations such as USP 797/825. SWE helps reinforce the Biodex commitment to streamline, facilitate and expand the use of theranostics and other radionuclide therapies, having a direct impact on patient outcome as stated earlier this year. >>

Leader in nuclear medicine and molecular imaging solutions, Biodex is providing a comprehensive approach for current and future theranostics and targeted therapies. Their wide range of products is solving the daily challenges of cancer diagnosis and treatment management in academic, research, industry and clinical settings across the globe. 

May 29, Shirley NY – According to the International Agency for Research on Cancer of the World Health Organization, the number of incident cases of cancer exceeded 18 million in 2018 and could potentially double by 2040. With a gigantic economic impact (total annual cost of cancer in 2010 reaching an approximate US $1.16 trillion) and strain on the healthcare space, Biodex is determined to streamline, facilitate and expand the use of theranostics and other radionuclide therapies having a direct impact on patient outcome. >>

Leader in nuclear medicine and molecular imaging solutions releases their latest Atomlab line with a sleek new design, enhanced user experience, and improved connectivity for the modern technologist or radiopharmacy. Featuring the intuitive functionality and superior accuracy Biodex products are known for, the new Atomlab Dose Calibrator and Wipe Test Counter add integration features that ensure longer life (or half-life) to the user.

October 12, 2017, Shirley NY – Following the initial unveiling at the June SNMMI in Denver, Biodex Medical Systems, Inc. brings the new Atomlab Dose Calibrator and Wipe Test Counter to market. With a large tablet display and improved software integration, Biodex positions this updated Atomlab product line as setting the stage for the future of nuclear medicine and imaging solutions. >>

February 17, 2015, Shirley, NY – Biodex is pleased to announce it will be participating in the 2015 European Congress of Radiology. Serving the medical profession for more than 60 years, Biodex manufactures and distributes devices for nuclear medicine, molecular imaging, and medical imaging applications.

Nuclear Medicine and Molecular Imaging

Biodex Medical Systems manufactures and distributes radiation shielding, protection and detection products for nuclear medicine, molecular imaging and radiation safety. Product offerings include dose calibrators, thyroid uptake, radiopharmaceutical chromatography, lung ventilation, exposure protection, cleanroom solutions, syringe shields, lead-lined cabinets, PET shipping systems and products to improve the image and procedure. >>

Biodex Medical Systems, Inc. exhibiting at Arab Health 2015

November 21, 2014
BIODEX PRESS RELEASE: Lila Corwin

November 21, 2014, Shirley, NY – Biodex is pleased to announce it will be participating in the 2015 Arab Health Exhibition and Congress.  Serving the medical profession for more than 60 years, Biodex manufactures and distributes devices for physical medicine, nuclear medicine and molecular imaging, and medical imaging applications. >>

 

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Read More